MedPath

Intracranial Pressure and Brain Function: Effects of Head Down Tilt Upon Brain Perfusion and Cognitive Performance

Not Applicable
Completed
Conditions
Intracranial Hypertension
Interventions
Other: 12° head down tilt
Registration Number
NCT02976168
Lead Sponsor
DLR German Aerospace Center
Brief Summary

The aim of the study is to understand the relationship between intracranial pressure regulation, cerebral tissue oxygenation and cognitive functioning. More specifically, the study tests the hypothesis that head down tilt will increase intracranial pressure (not measured in this study, but demonstrated in previous studies), will induce venous congestion and facial swelling, decrease intracranial tissue oxygenation and hamper brain functioning. The objectives of the study therefore are to assess young healthy people during head-down tilt (HDT), and to assess cognitive brain functioning, cerebral tissue oxygenation (non-invasively), frontal skin thickness, cerebral perfusion and neuronal functioning via event-related potentials.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
13
Inclusion Criteria
  • Physically and mentally healthy male test subjects that are able and declare in writing their willingness to participate in the entire study and successfully passed the psychological and medical screening
  • Aged between 18-55 years old with a Body Mass Index (BMI) of 20-28 kg/m2, weight between 65-100 kg, and a height between 158-195 cm
  • Demonstrable medical insurance and official certificate of absence of criminal record
Exclusion Criteria
  • Inability to sleep on the back
  • Drug, medication or alcohol abuse (regular consumption of more than 20-30 g alcohol/day)
  • Smoking within the past 6 months prior to study commencement
  • Migraine or other chronic head aches
  • Previous psychiatric illness
  • Subjects suffering from weak concentration
  • History of psychological or central nervous disorders
  • Hiatus hernia
  • Gastro-oesophageal reflux
  • Diabetes mellitus
  • Pronounced orthostatic intolerance (< 10 min standing)
  • Kidney disorder: deviations from normal values for creatinine in plasma. (Normal value: Creatinine < 1.20 mg/dl)
  • Thyroid gland disorder: deviations from normal values for thyroid stimulating Hormone (TSH) in plasma. (Normal range: TSH 0.55-4.80 mUnits/l)
  • Anaemia: Hb under normal values (Normal values of Hb for men: 13.5-17.5 g/l)
  • Elevated risk of thrombosis
  • High likelihood of coagulopathy assessed by a clinical standard questionnaire
  • Chronic back complaints
  • History of lumbar surgery
  • History of lumbar spine trauma
  • Motor or sensory deficits as assessed by neurological examination
  • Contraindications against MRI
  • Imprisoned at the time of the study
  • Taking medications that may impair cognitive function, autonomic function or any of the study procedures
  • Ophthalmological conditions including glaucoma, retinopathy, severe cataracts, eye trauma or implants
  • Any other medical condition that the investigators consider a contraindication to the study procedures that would make it unsafe or confound the measurements.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
-12° head down tilt12° head down tiltSubjects will be in 12° head down supine Position for 21 hours
Primary Outcome Measures
NameTimeMethod
Change in cognitive test battery scoreTwice at baseline, and 30 minutes and 20 hours after starting the intervention

The test battery includes sensomotoric speed, psychomotor vigilance, visual analysis of items, abstract thinking and mathematical processing

Secondary Outcome Measures
NameTimeMethod
Change in total sleep timefrom 22:00 until 6:00 in all nights

Polysomnographic recordings

Change in mid cerebral artery blood flow velocityTwice at baseline, and 10 minutes and 19 hours after starting the intervention

Transcranial Doppler measurements

Magnetic resonance Imaging: Change in resting state functional MRI (fMRI)Once at baseline, and 2 and 19 hours after starting the intervention

Magnetic resonance imaging will be performed to assess resting state functional MRI.

Change in P-300Twice at baseline, and 30 minutes and 20 hours after starting the intervention

P-300 will be assessed via an EEG electrode during cognitive test battery

Magnetic resonance Imaging: Change in fMRI Response to decision taskOnce at baseline, and 2 and 19 hours after starting the intervention

Magnetic resonance imaging will be performed in order to assess functional MRI during a decision task combing a reaction time test using a visual stimulus.

Change in cerebral tissue oxygenationTwice at baseline, and 10 minutes and 19 hours after starting the intervention

Near-infrared measurement

Magnetic resonance Imaging: Change in cerebral blood flowOnce at baseline, and 2 and 19 hours after starting the intervention

Magnetic resonance imaging will be performed in order to gain information about intracranial blood flow.

Change in frontal vein fillingOnce at baseline, and 10 minutes and 19 hours after starting the intervention

Conventional Imaging ultrasound from the frontal veins will be used to assess vein cross sections

Change in jugular vein fillingOnce at baseline, and 10 minutes and 19 hours after starting the intervention

Conventional Imaging ultrasound from jugular veins veins will be used to assess vein cross sections

Change in sleep effectivenessover the entire intervention night

Polysomnographic recordings

Trial Locations

Locations (1)

DLR German Aerospace Center

🇩🇪

Cologne, Germany

© Copyright 2025. All Rights Reserved by MedPath